Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICP-B208 in Advanced Solid Tumors
NCT07617493Phase 2Recruiting
- Sponsor
- InnoCare Pharma
- Start
- Jul 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
A Phase 2 trial of ICP-B208 in solid tumor, sponsored by InnoCare Pharma. Started Jul 2026; status: recruiting.
02
Drugs
ICP-B208
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07617493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07617493.